These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 22893357

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial.
    Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almås B, Jorde R.
    Osteoporos Int; 2012 Jan; 23(1):201-11. PubMed ID: 21909730
    [Abstract] [Full Text] [Related]

  • 4. A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis.
    Huang J, Meixner L, Fernandez S, McCutchan JA.
    AIDS; 2009 Jan 02; 23(1):51-7. PubMed ID: 19050386
    [Abstract] [Full Text] [Related]

  • 5. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A, Constancio L, Fogelman I, Hampson G.
    BMC Musculoskelet Disord; 2007 Jan 10; 8():3. PubMed ID: 17214897
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5-Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open-Label Extension of a Randomized Controlled Trial.
    Grey A, Bolland MJ, Horne A, Mihov B, Gamble G, Reid IR.
    J Bone Miner Res; 2022 Jan 10; 37(1):3-11. PubMed ID: 34585780
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years.
    Negredo E, Bonjoch A, Pérez-Álvarez N, Ornelas A, Puig J, Herrero C, Estany C, del Río L, di Gregorio S, Echeverría P, Clotet B.
    HIV Med; 2015 Aug 10; 16(7):441-8. PubMed ID: 25944411
    [Abstract] [Full Text] [Related]

  • 11. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.
    Naylor KE, Bradburn M, Paggiosi MA, Gossiel F, Peel NFA, McCloskey EV, Walsh JS, Eastell R.
    Osteoporos Int; 2018 Jun 10; 29(6):1407-1417. PubMed ID: 29525970
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.
    Grey A, Bolland MJ, Horne A, Wattie D, House M, Gamble G, Reid IR.
    Bone; 2012 Jun 10; 50(6):1389-93. PubMed ID: 22465268
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
    Popp AW, Senn R, Curkovic I, Senn C, Buffat H, Popp PF, Lippuner K.
    Osteoporos Int; 2017 Jun 10; 28(6):1995-2002. PubMed ID: 28299378
    [Abstract] [Full Text] [Related]

  • 18. Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment.
    Bianchi ML, Morandi L, Andreucci E, Vai S, Frasunkiewicz J, Cottafava R.
    Osteoporos Int; 2011 Feb 10; 22(2):529-39. PubMed ID: 20458570
    [Abstract] [Full Text] [Related]

  • 19. Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months.
    Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Callon KE, Gamble GD, Reid IR.
    J Bone Miner Res; 2008 Aug 10; 23(8):1304-8. PubMed ID: 18627266
    [Abstract] [Full Text] [Related]

  • 20. 25-Hydroxyvitamin D Threshold for the Effects of Vitamin D Supplements on Bone Density: Secondary Analysis of a Randomized Controlled Trial.
    Macdonald HM, Reid IR, Gamble GD, Fraser WD, Tang JC, Wood AD.
    J Bone Miner Res; 2018 Aug 10; 33(8):1464-1469. PubMed ID: 29665087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.